Cronos (CRON) Cash from Financing Activities (2019 - 2026)
Cronos (CRON) posted quarterly Cash from Financing Activities of -$18.3 million for Q1 2026, down 523.48% year-over-year from $4.3 million in Q1 2025, and down 146.1% quarter-over-quarter from -$7.4 million in Q4 2025.
Cronos (CRON) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Cronos' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at -$18.3 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 523.48% year-over-year to -$18.3 million; the TTM figure through Mar 2026 stood at -$35.2 million (down 902.36% YoY), while the FY2025 annual figure was -$19.9 million, down 1516.98% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$18.3 million, down from -$7.4 million in the prior quarter.
- The five-year high for Cash from Financing Activities was -$13000.0 in Q3 2024, with the low at -$18.3 million in Q1 2026.
- The 5-year median for Cash from Financing Activities is -$620000.0 (2022), against an average of -$2.5 million.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 97.52% in 2023, then tumbled 14253.85% in 2025.
- Cronos' Cash from Financing Activities stood at -$620000.0 in 2022, then surged by 64.84% to -$218000.0 in 2023, then tumbled by 43.58% to -$313000.0 in 2024, then slumped by 2271.57% to -$7.4 million in 2025, then plunged by 146.1% to -$18.3 million in 2026.
- Business Quant data shows CRON's Cash from Financing Activities at -$18.3 million in Q1 2026, -$7.4 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | -20.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.88 Mn |
| Jun 30, 2026 | -20.88 Mn |
| Mar 31, 2026 | -18.27 Mn |
| Mar 31, 2026 | -18.27 Mn |
| Dec 31, 2025 | -7.42 Mn |
| Dec 31, 2025 | -7.42 Mn |
| Sep 30, 2025 | -1.87 Mn |
| Sep 30, 2025 | -1.87 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Mar 31, 2025 | -2.93 Mn |
| Mar 31, 2025 | -2.93 Mn |
| Dec 31, 2024 | -313,000.00 |
| Dec 31, 2024 | -313,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Mar 31, 2024 | -645,000.00 |
| Mar 31, 2024 | -645,000.00 |